Dykan Jeff has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Dykan Jeff is identified in SEC filings as a Director of Regentis Biomaterials Ltd. as of the filing dated 2026-07-13. Public biographical information about this individual is limited in the provided context. The name may appear in other sources as Jeff Dykan or in other name variations. Based on the available SEC context, he serves on the board of Regentis Biomaterials Ltd., likely contributing to governance and oversight of the company's strategic initiatives in biomaterials. No additional verified details about education, career history, or prior board roles are readily accessible from the supplied information.
Role
Director
Notability
30/100
Board memberships
Regentis Biomaterials Ltd.
Awards & honors
Listed as Director of Regentis Biomaterials Ltd. in SEC filings dated 2026-07-13
Dykan Jeff is identified in SEC filings as a Director of Regentis Biomaterials Ltd. as of the filing dated 2026-07-13. Public biographical information about this individual is limited in the provided context. The name may appear in other sources as Jeff Dykan or in other name variations. Based on the available SEC context, he serves on the board of Regentis Biomaterials Ltd., l…
How many SEC Form 4 filings has Dykan Jeff submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Dykan Jeff's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
